| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |